These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of mutations in aclacinomycin A-non-producing Streptomyces galilaeus strains with altered glycosylation patterns. Räty K, Hautala A, Torkkell S, Kantola J, Mäntsälä P, Hakala J, Ylihonko K. Microbiology (Reading); 2002 Nov; 148(Pt 11):3375-3384. PubMed ID: 12427929 [Abstract] [Full Text] [Related]
3. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone. Oki T, Yoshimoto A, Matsuzawa Y, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952 [Abstract] [Full Text] [Related]
4. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin. Hwang CK, Kim HS, Hong YS, Kim YH, Hong SK, Kim SJ, Lee JJ. Antimicrob Agents Chemother; 1995 Jul; 39(7):1616-20. PubMed ID: 7492117 [Abstract] [Full Text] [Related]
5. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133. Kim HS, Hong YS, Kim YH, Yoo OJ, Lee JJ. J Antibiot (Tokyo); 1996 Apr; 49(4):355-60. PubMed ID: 8641998 [Abstract] [Full Text] [Related]
6. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants. Yoshimoto A, Matsuzawa Y, Oki T, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976 [Abstract] [Full Text] [Related]
7. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products. Wang Y, Niemi J, Mäntsälä P. FEMS Microbiol Lett; 2002 Feb 19; 208(1):117-22. PubMed ID: 11934504 [Abstract] [Full Text] [Related]
8. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin. Räty K, Kunnari T, Hakala J, Mäntsälä P, Ylihonko K. Mol Gen Genet; 2000 Sep 19; 264(1-2):164-72. PubMed ID: 11016846 [Abstract] [Full Text] [Related]
9. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides. Matsuzawa Y, Yoshimoto A, Shibamoto N, Tobe H, Oki T, Naganawa H, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1981 Aug 19; 34(8):959-64. PubMed ID: 7319928 [Abstract] [Full Text] [Related]
15. Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius. Schumann G, Stengel C, Eckardt K, Ihn W. J Basic Microbiol; 1986 Aug 19; 26(4):249-55. PubMed ID: 3464736 [Abstract] [Full Text] [Related]
16. Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline. Kantola J, Blanco G, Hautala A, Kunnari T, Hakala J, Mendez C, Ylihonko K, Mäntsälä P, Salas J. Chem Biol; 1997 Oct 19; 4(10):751-5. PubMed ID: 9375253 [Abstract] [Full Text] [Related]
17. Cloning of aklavinone biosynthesis genes from Streptomyces galilaeus. Tsukamoto N, Fujii I, Ebizuka Y, Sankawa U. J Antibiot (Tokyo); 1992 Aug 19; 45(8):1286-94. PubMed ID: 1399850 [Abstract] [Full Text] [Related]
18. Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus. Niemi J, Ylihonko K, Hakala J, Pärssinen R, Kopio A, Mäntsälä P. Microbiology (Reading); 1994 Jun 19; 140 ( Pt 6)():1351-8. PubMed ID: 8081500 [Abstract] [Full Text] [Related]
19. AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A. Lu W, Leimkuhler C, Oberthür M, Kahne D, Walsh CT. Biochemistry; 2004 Apr 20; 43(15):4548-58. PubMed ID: 15078101 [Abstract] [Full Text] [Related]
20. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant. Johdo O, Yoshioka T, Naganawa H, Takeuchi T, Yoshimoto A. J Antibiot (Tokyo); 1996 Jul 20; 49(7):669-75. PubMed ID: 8784429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]